Ablynx nearly doubles revenues in 2009 first half

Ablynx NV nearly doubled its revenues to €11.9 million in the first half of 2009 following milestone payments from its research collaborators, Novartis, Wyeth, Boehringer Ingelheim and Merck Serono.